EG17979A - Method for preparing injectable sustained release formulation from somatotropine - Google Patents

Method for preparing injectable sustained release formulation from somatotropine

Info

Publication number
EG17979A
EG17979A EG530/86A EG53086A EG17979A EG 17979 A EG17979 A EG 17979A EG 530/86 A EG530/86 A EG 530/86A EG 53086 A EG53086 A EG 53086A EG 17979 A EG17979 A EG 17979A
Authority
EG
Egypt
Prior art keywords
somatotropine
sustained release
release formulation
injectable sustained
preparing injectable
Prior art date
Application number
EG530/86A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of EG17979A publication Critical patent/EG17979A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EG530/86A 1985-08-23 1986-08-20 Method for preparing injectable sustained release formulation from somatotropine EG17979A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76860585A 1985-08-23 1985-08-23

Publications (1)

Publication Number Publication Date
EG17979A true EG17979A (en) 1992-06-30

Family

ID=25082968

Family Applications (1)

Application Number Title Priority Date Filing Date
EG530/86A EG17979A (en) 1985-08-23 1986-08-20 Method for preparing injectable sustained release formulation from somatotropine

Country Status (13)

Country Link
EP (1) EP0211691A3 (fr)
JP (1) JPS6251624A (fr)
CN (1) CN1006197B (fr)
AU (1) AU591516B2 (fr)
CA (1) CA1285874C (fr)
DK (1) DK396286A (fr)
EG (1) EG17979A (fr)
HU (1) HU195425B (fr)
IL (1) IL79765A (fr)
NZ (1) NZ217267A (fr)
PH (1) PH25861A (fr)
SU (1) SU1683493A3 (fr)
ZA (1) ZA866218B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1296253C (fr) * 1986-10-20 1992-02-25 Praveen Tyle Compositions d'hormones de croissance stabilisees
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US4857505A (en) * 1987-03-09 1989-08-15 American Cyanamid Company Sustained release compositions for parenteral administration and their use
GB8725427D0 (en) * 1987-10-30 1987-12-02 Lilly Industries Ltd Somatotropin formulations
US5021554A (en) * 1989-02-24 1991-06-04 Eli Lilly And Company Process for protein particle size reduction using a fluid-energy mill
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
IL103275A0 (en) * 1991-10-01 1993-02-21 Lilly Co Eli Injectable extended release formulations and methods
SE9303068D0 (sv) * 1993-09-21 1993-09-21 Kabi Pharmacia Ab New use
CN1062129C (zh) * 1995-09-14 2001-02-21 徐荣祥 药物基质及其用途
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
US6972195B2 (en) 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
CN1827766B (zh) 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6685971B2 (en) 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2493202A (en) * 1946-06-07 1950-01-03 Merck & Co Inc Process of making a fluid oil-beeswax vehicle for the parenteral administration of drugs
BE795516A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation
EP0085036A1 (fr) * 1982-01-18 1983-08-03 Monsanto Company Méthode pour une production améliorée de lait de bovins
US4521409A (en) * 1983-10-03 1985-06-04 Cornell Research Foundation, Inc. Use of growth hormone to enhance ruminant mammary development
HU196714B (en) * 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
IL79681A (en) * 1985-08-12 1991-06-10 Int Minerals & Chem Corp Transition metal complexes of growth hormones and their prolonged release compositions
US4775659A (en) * 1985-08-19 1988-10-04 Eli Lilly And Company Injectable semi-solid formulations

Also Published As

Publication number Publication date
DK396286D0 (da) 1986-08-20
CN1006197B (zh) 1989-12-27
ZA866218B (en) 1988-03-30
NZ217267A (en) 1989-02-24
HUT41637A (en) 1987-05-28
DK396286A (da) 1987-02-24
IL79765A (en) 1992-02-16
PH25861A (en) 1991-12-02
CA1285874C (fr) 1991-07-09
EP0211691A3 (fr) 1987-06-03
CN86105087A (zh) 1987-03-04
EP0211691A2 (fr) 1987-02-25
SU1683493A3 (ru) 1991-10-07
HU195425B (en) 1988-05-30
AU591516B2 (en) 1989-12-07
AU6170086A (en) 1987-02-26
JPS6251624A (ja) 1987-03-06

Similar Documents

Publication Publication Date Title
IL78960A0 (en) Method for preparing infectionresistant materials
EP0311983A3 (en) Method for the preparation of titanium-silicalites
GR861583B (en) Method for preparing new 2-arylimidazolines
EG17979A (en) Method for preparing injectable sustained release formulation from somatotropine
NZ223950A (en) Method for preparing ibuprofen
GR890100769A (en) Method for preparing (s)-a-ethyl-2-oxo-1-pyrrolidineacetamide
GR900100165A (en) Method for preparing sulfo-triazolo-diazepino-derivatives
GR862030B (en) Method for preparing pharmaceutical compositions
GR862183B (en) Method for preparing aminoacid derivatives
IL90665A0 (en) Method for preparing pyrazole-carboxylic acid derivatives
GR862769B (en) Method for preparing a-hydroxycarbonyl compounds
EP0214651A3 (en) Method for preparing 3-ethylbenzophenone
GR862191B (en) Method for preparing novel hydropyridin derivatives
ZA887372B (en) Method for the preparation of anilinofumarate
EP0281305A3 (en) Method for preparing aminohydrocarbyl-substituted ketoximosilanes
EP0215439A3 (en) Method for preparing 3-ethylbenzophenone
EP0297447A3 (en) Method for the preparation of 2-cyclopentenones
GR862415B (en) Method for preparing chinolin derivatives
GR862007B (en) Method for preparing cyclo-alifatic cetoamines
GR870422B (en) Method for preparing pharmaceutical compositions containing vinburnine
IE862241L (en) Injectable sustained release formulation
GR862100B (en) Method for preparing novel benzodioxepanne
PL276494A1 (en) Method for the tionaphthene preparation
BG42762A1 (en) Method for preparing unsaturated polyaminoesteramides
BG41904A1 (en) Method for preparing alkyl- phosphonous acids